Correction: Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification

Affiliations

¹ Department of Ophthalmology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
² Department of Orthopedics, The Shanghai Tenth People's Hospital of Tongji University, Shanghai, China.
³ Department of Rheumatology and Immunology, The First People's Hospital of Xuzhou, Xuzhou, 221002, Jiangsu, People's Republic of China. 13685138802@163.com.
⁴ Department of Dermatology, Xuzhou Municipal Hospital Affiliated With Xuzhou Medical University, Xuzhou, 221002, Jiangsu, People's Republic of China. gzq199207@163.com.
⁵ Department of Ophthalmology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. jiangyanyun@163.com.

^# Contributed equally.

Published Erratum

Liying Luo et al. Mol Med. 2023.

. 2023 Apr 21;29(1):56.

doi: 10.1186/s10020-023-00654-1.

¹ Department of Ophthalmology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
² Department of Orthopedics, The Shanghai Tenth People's Hospital of Tongji University, Shanghai, China.
³ Department of Rheumatology and Immunology, The First People's Hospital of Xuzhou, Xuzhou, 221002, Jiangsu, People's Republic of China. 13685138802@163.com.
⁴ Department of Dermatology, Xuzhou Municipal Hospital Affiliated With Xuzhou Medical University, Xuzhou, 221002, Jiangsu, People's Republic of China. gzq199207@163.com.
⁵ Department of Ophthalmology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. jiangyanyun@163.com.

^# Contributed equally.

No abstract available

Erratum for

Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification.
Luo L, Guan Z, Jin X, Guan Z, Jiang Y. Luo L, et al. Mol Med. 2023 Mar 20;29(1):36. doi: 10.1186/s10020-023-00625-6. Mol Med. 2023. PMID: 36941586 Free PMC article.